{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Benzodiazepine site", "GABAA receptor", "Medicinal plants", "Molecular docking", "Pharmacophore model"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35747359", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jtcme.2021.08.012"], "Journal": {"ISSN": "2225-4110", "JournalIssue": {"Volume": "12", "Issue": "4", "PubDate": {"Year": "2022", "Month": "Jul"}}, "Title": "Journal of traditional and complementary medicine", "ISOAbbreviation": "J Tradit Complement Med"}, "ArticleTitle": "Mechanism of action involved in the anxiolytic-like effects of Hibalactone isolated from <i>Hydrocotyle umbellata</i> L.", "Pagination": {"StartPage": "318", "EndPage": "329", "MedlinePgn": "318-329"}, "Abstract": {"AbstractText": ["Hibalactone (HB) is a lignan related to the anxiolytic-like effects of <i>Hydrocotyle umbellata</i> L. However, there is a need to understand better the mechanism of action of this lignan to support the ethnopharmacological uses of the species. This work aimed to evaluate by <i>in\u00a0vivo</i> and <i>in silico</i> analysis the mechanism of action of HB involved in its anxiolytic-like effects.", "The effects of HB in mice were evaluated on light-dark box (LDB) and elevated plus maze (EPM) tests. The participation of 5-HT<sub>1A</sub> receptor and the benzodiazepine site of GABA<sub>A</sub> receptor was evaluated to investigate the possible mechanism of action. <i>In silico</i> tools were used to better elucidate the anxiolytic-like effects of HB.", "Oral treatment with HB at a dose of 33\u00a0mg/kg showed an anxiolytic-like effect in the LDB and EPM tests. Besides that, the treatment altered the ethological parameters, frequency of head dips, and stretched-attend postures (SAP), important to better describe the anxiolytic profile of HB. Pretreatment with flumazenil (2\u00a0mg/kg) reverted the anxiolytic-like effect of HB on LDB and EPM tests. On the other hand, pretreatment with NAN-190 (0.5\u00a0mg/kg) not reverted the activity observed. <i>In silico</i> predictions revealed the potential of HB to increase GABAergic neurotransmission. Pharmacophore modelling and docking simulations showed that HB might interact with the \u03b11\u03b22\u03b32 GABA<sub>A</sub> receptor.", "Together, the results presented herein suggest that activation of the benzodiazepine site of the GABA<sub>A</sub> receptor contributes to the anxiolytic-like effect of HB."], "CopyrightInformation": "\u00a9 2021 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculdade de Farm\u00e1cia, Universidade Federal de Goi\u00e1s, Av. Universit\u00e1ria com 1 Avenida s/n, Setor Universit\u00e1rio, 74605-220, Goi\u00e2nia, Goi\u00e1s, Brazil."}], "LastName": "Gabriel de Oliveira", "ForeName": "Matheus", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laborat\u00f3rio de Farmacologia de Produtos Naturais e Sint\u00e9ticos, Universidade Federal de Goi\u00e1s, Avenida Esperan\u00e7a, s/n Campus Samambaia, 74690-900, Goi\u00e2nia, Goi\u00e1s, Brazil."}], "LastName": "Kelle da Silva Moreira", "ForeName": "Lorrane", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laborat\u00f3rio de Farmacologia de Produtos Naturais e Sint\u00e9ticos, Universidade Federal de Goi\u00e1s, Avenida Esperan\u00e7a, s/n Campus Samambaia, 74690-900, Goi\u00e2nia, Goi\u00e1s, Brazil."}], "LastName": "Turones", "ForeName": "Larissa Cordova", "Initials": "LC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laborat\u00f3rio de Farmacologia de Produtos Naturais e Sint\u00e9ticos, Universidade Federal de Goi\u00e1s, Avenida Esperan\u00e7a, s/n Campus Samambaia, 74690-900, Goi\u00e2nia, Goi\u00e1s, Brazil."}], "LastName": "de Souza Almeida", "ForeName": "Dionys", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laborat\u00f3rio de Farmacologia de Produtos Naturais e Sint\u00e9ticos, Universidade Federal de Goi\u00e1s, Avenida Esperan\u00e7a, s/n Campus Samambaia, 74690-900, Goi\u00e2nia, Goi\u00e1s, Brazil."}], "LastName": "Martins", "ForeName": "Aline Nazareth", "Initials": "AN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculdade de Farm\u00e1cia, Universidade Federal de Goi\u00e1s, Av. Universit\u00e1ria com 1 Avenida s/n, Setor Universit\u00e1rio, 74605-220, Goi\u00e2nia, Goi\u00e1s, Brazil."}], "LastName": "Silva Oliveira", "ForeName": "Thiago Levi", "Initials": "TL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Escola de Ci\u00eancias M\u00e9dicas e da Vida, Pontif\u00edcia Universidade Cat\u00f3lica de Goi\u00e1s, Avenida Universit\u00e1ria 1.440, Setor Leste Universit\u00e1rio, 74605-010, Goi\u00e2nia, Goi\u00e1s, Brazil."}], "LastName": "Barreto da Silva", "ForeName": "Vinicius", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Escola de Ci\u00eancias M\u00e9dicas e da Vida, Pontif\u00edcia Universidade Cat\u00f3lica de Goi\u00e1s, Avenida Universit\u00e1ria 1.440, Setor Leste Universit\u00e1rio, 74605-010, Goi\u00e2nia, Goi\u00e1s, Brazil."}], "LastName": "Borges", "ForeName": "Leonardo Luiz", "Initials": "LL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laborat\u00f3rio de Farmacologia de Produtos Naturais e Sint\u00e9ticos, Universidade Federal de Goi\u00e1s, Avenida Esperan\u00e7a, s/n Campus Samambaia, 74690-900, Goi\u00e2nia, Goi\u00e1s, Brazil."}], "LastName": "Costa", "ForeName": "Elson Alves", "Initials": "EA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculdade de Farm\u00e1cia, Universidade Federal de Goi\u00e1s, Av. Universit\u00e1ria com 1 Avenida s/n, Setor Universit\u00e1rio, 74605-220, Goi\u00e2nia, Goi\u00e1s, Brazil."}], "LastName": "Realino de Paula", "ForeName": "Jos\u00e9", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "J Tradit Complement Med", "NlmUniqueID": "101605474", "ISSNLinking": "2225-4110"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Craske M.G., Stein M.B., Eley T.C., et al. Anxiety disorders. Nat Rev Dis Primers. 2017;3:17024. doi: 10.1038/nrdp.2017.24.", "ArticleIdList": ["10.1038/nrdp.2017.24", "28470168"]}, {"Citation": "Nuss P. Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatric Dis Treat. 2015;11:165\u2013175. doi: 10.2147/2FNDT.S58841.", "ArticleIdList": ["10.2147/2FNDT.S58841", "PMC4303399", "25653526"]}, {"Citation": "Lader M. Benzodiazepines revisited \u2013 will we ever learn? Addiction. 2011;106(12):2086\u20132109. doi: 10.1111/j.1360-0443.2011.03563.x.", "ArticleIdList": ["10.1111/j.1360-0443.2011.03563.x", "21714826"]}, {"Citation": "Griffin C.E., 3rd, Kaye A.M., Bueno F.R., Kaye A.D. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13(2):214\u2013223.", "ArticleIdList": ["PMC3684331", "23789008"]}, {"Citation": "Griebel G., Holmes A. 50 years of hurdles and hope in anxiolytic drug discovery. Nat Rev Drug Discov. 2013;12(9):667\u2013687. doi: 10.1038/nrd4075.", "ArticleIdList": ["10.1038/nrd4075", "PMC4176700", "23989795"]}, {"Citation": "Lundstrom K., Pham H.T., Dinh L.D. Interaction of plant extracts with central nervous system receptors. Medicines (Basel) 2017;4(1):12. doi: 10.3390/medicines4010012.", "ArticleIdList": ["10.3390/medicines4010012", "PMC5597072", "28930228"]}, {"Citation": "Kumar V. Potential medicinal plants for CNS disorders: an overview. Phytother Res. 2006;20:1023\u20131035. doi: 10.1002/ptr.1970.", "ArticleIdList": ["10.1002/ptr.1970", "16909441"]}, {"Citation": "Sharma A., Cardoso-Taketa A., Garcia G., Villarreal M.L. A\u00a0systematic updated review of scientifically tested selected plants used for anxiety disorders. Botanics Targets Ther. 2012;2:21\u201339. doi: 10.2147/BTAT.S20593.", "ArticleIdList": ["10.2147/BTAT.S20593"]}, {"Citation": "Ficher D.C.H., Kato E.T.M., Oliveira F. Estudo farmacogn\u00f3stico de Hydrocotyle bonariensis Lam., adulterante de Centella asiatica (L.) Urban Lecta Rev Farm Biol. 1994;12:71\u2013102."}, {"Citation": "Oliveira T.L.S., Morais S.R., S\u00e1 S., et al. Antinociceptive, anti-inflammatory and anxiolytic-like effects of the ethanolic extract, fractions and hibalactone isolated from Hydrocotyle umbellata L. (Acari\u00e7oba) \u2013 Araliaceae. Biomed Pharmacother. 2017;95:837\u2013846. doi: 10.1016/j.biopha.2017.08.140.", "ArticleIdList": ["10.1016/j.biopha.2017.08.140", "28903179"]}, {"Citation": "Takaku N., Choi D.H., Mikame K., et al. Lignans of Chamaecyparis obtuse. J\u00a0Wood Sci. 2001;47:476\u2013482."}, {"Citation": "De Oliveira M.G., De Almeida P.H., Oliveira T.L., et al. HPLC-PDA method validated for the determination of hibalactone in Hydrocotyle umbellata subterraneous parts and its ultrasound-assisted extraction optimization. Rev Bras de Farm. 2019;29:162\u2013170. doi: 10.1016/j.bjp.2018.10.003.", "ArticleIdList": ["10.1016/j.bjp.2018.10.003"]}, {"Citation": "De Brito A.F., Martins J.L., Fajemiroye J.O., et al. Central pharmacological activity of a new piperazine derivative: 4-(1-phenyl-1H-pyrazol-4-ylmethyl)-piperazine-1-carboxylic acid ethyl ester. Life Sci. 2012;90(23-24):910\u2013916. doi: 10.1016/j.lfs.2012.04.037.", "ArticleIdList": ["10.1016/j.lfs.2012.04.037", "22564406"]}, {"Citation": "Moreira L.K., De Brito A.F., Fontana C., et al. Neuropharmacological assessment in mice and molecular docking of piperazine derivative LQFM212. Behav Brain Res. 2020;394:112827. doi: 10.1016/j.bbr.2020.112827.", "ArticleIdList": ["10.1016/j.bbr.2020.112827", "32730857"]}, {"Citation": "Crawley J.N., Goodwin F.K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav. 1980;13:167\u2013170. doi: 10.1016/0091-3057(80)90067-2.", "ArticleIdList": ["10.1016/0091-3057(80)90067-2", "6106204"]}, {"Citation": "Bourin M., Hasco\u00ebt M. The mouse light-dark box test. Eur J Pharmacol. 2003;463(1-3):55\u201365. doi: 10.1016/S0014-2999(03)01274-3.", "ArticleIdList": ["10.1016/S0014-2999(03)01274-3", "12600702"]}, {"Citation": "Lister R.G. The use of a plus maze to measure anxiety in the mouse. Psychopharmacology. 1987;92:180\u2013185. doi: 10.1007/bf00177912.", "ArticleIdList": ["10.1007/bf00177912", "3110839"]}, {"Citation": "Komada M., Takao K., Miyakawa T. Elevated plus maze for mice. J\u00a0Vis Exp. 2008;22:e1088.", "ArticleIdList": ["PMC2762911", "19229173"]}, {"Citation": "Lagunin A., Stepanchikova A., Filimonov D., Poroikov V. PASS: prediction of activity spectra for biologically active substances. Bioinformatics. 2000;16(8):747\u2013748. doi: 10.1093/bioinformatics/16.8.747.", "ArticleIdList": ["10.1093/bioinformatics/16.8.747", "11099264"]}, {"Citation": "Lagunin A., Ivanov S., Rudik A., Filimonov D., Poroikov V. DIGEP-Pred: web service for in silico prediction of drug-induced gene expression profiles based on structural formula. Bioinformatics. 2013;29(16):2062\u20132063. doi: 10.1093/bioinformatics/btt322.", "ArticleIdList": ["10.1093/bioinformatics/btt322", "23740741"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47:W357\u2013W364. doi: 10.1093/nar/gkz382.", "ArticleIdList": ["10.1093/nar/gkz382", "PMC6602486", "31106366"]}, {"Citation": "Liu T., Lin Y., Wen X., Jorissen R.N., Gilson M.K. BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res. 2007;35:D198\u2013D201. doi: 10.1093/nar/gkl999.", "ArticleIdList": ["10.1093/nar/gkl999", "PMC1751547", "17145705"]}, {"Citation": "Kim S., Thiessen P.A., Bolton E.E., et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44:D1202\u2013D1213. doi: 10.1093/nar/gkv951.", "ArticleIdList": ["10.1093/nar/gkv951", "PMC4702940", "26400175"]}, {"Citation": "Hintermann S., Hurth K., Nozulak J., et al. Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABAA receptor. Bioorg Med Chem Lett. 2011;21(5):1523\u20131526. doi: 10.1016/j.bmcl.2010.12.107.", "ArticleIdList": ["10.1016/j.bmcl.2010.12.107", "21277199"]}, {"Citation": "Larsen J.S., Ahring P.K., Nielsen E.\u00d8., Mirza N. 2013. Benzimidazole Derivatives and Their Use for Modulating the GABAA Receptor Complex; p. US8492408."}, {"Citation": "Olivier A., Sevrin M., Durant F. A\u00a0conformational study of ligands for omega modulatory sites of GABAA receptors by NOESY NMR spectroscopy and distance geometry. Bioorg Med Chem Lett. 1997;7(17):2277\u20132282. doi: 10.1016/S0960-894X(97)00404-6.", "ArticleIdList": ["10.1016/S0960-894X(97)00404-6"]}, {"Citation": "Schneidman-Duhovny D., Dror O., Inbar Y., Nussinov R., Wolfson H.J. PharmaGist: a webserver for ligand-based pharmacophore detection. Nucleic Acids Res. 2008;36:W223-W228. doi: 10.1093/nar/gkn187.", "ArticleIdList": ["10.1093/nar/gkn187", "PMC2447755", "18424800"]}, {"Citation": "Zhu S., Noviello C.M., Teng J., Walsh R.M., Jr., Kim J.J., Hibbs R.E. Structure of a human synaptic GABAA receptor. Nature. 2018;559:67\u201372. doi: 10.1038/s41586-018-0255-3.", "ArticleIdList": ["10.1038/s41586-018-0255-3", "PMC6220708", "29950725"]}, {"Citation": "Dos Santos K.B., Guedes I.A., Karl A.L.M., Dardenne L.E. Highly flexible ligand docking: benchmarking of the DockThor program on the LEADS-PEP protein-peptide dataset. J\u00a0Chem Inf Model. 2020;60(2):667\u2013683. doi: 10.1021/acs.jcim.9b00905.", "ArticleIdList": ["10.1021/acs.jcim.9b00905", "31922754"]}, {"Citation": "Gohlke H., Hendlich M., Klebe G. Knowledge-based scoring function to predict protein-ligand interactions. J\u00a0Mol Biol. 2000;14(2):337\u2013356. doi: 10.1006/jmbi.1999.3371. 295.", "ArticleIdList": ["10.1006/jmbi.1999.3371", "10623530"]}, {"Citation": "Apers S., Vlietinck A., Pieters L. Lignans and neolignans as lead compounds. Phytochemistry Rev. 2003;2(3):201\u2013217."}, {"Citation": "Ramos A. Animal models of anxiety: do I need multiple tests? Trends Pharmacol Sci. 2008;29(10):493\u2013498. doi: 10.1016/j.tips.2008.07.005.", "ArticleIdList": ["10.1016/j.tips.2008.07.005", "18755516"]}, {"Citation": "Ennaceur A., Chazot P.L. Preclinical animal anxiety research - flaws and prejudices. Pharmacol Res. 2016;4 doi: 10.1002/prp2.223. Perspect.", "ArticleIdList": ["10.1002/prp2.223", "PMC4804324", "27069634"]}, {"Citation": "Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., Dourish C.T. Behavioural and pharmacological characterization of the elevated \"zero-maze\" as an animal model of anxiety. Psychopharmacology. 1994;116:56\u201364. doi: 10.1007/BF02244871.", "ArticleIdList": ["10.1007/BF02244871", "7862931"]}, {"Citation": "Nuss P. Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatric Dis Treat. 2015;11:165\u2013175. doi: 10.2147/NDT.S58841.", "ArticleIdList": ["10.2147/NDT.S58841", "PMC4303399", "25653526"]}, {"Citation": "Olivier J.D.A., Vinkers C.H., Olivier B. The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders. Front Pharmacol. 2013;4:74. doi: 10.3389/fphar.2013.00074.", "ArticleIdList": ["10.3389/fphar.2013.00074", "PMC3677985", "23781201"]}, {"Citation": "Gilhotra N., Dhingra D. Neurochemical modulation of anxiety disorders. Int J Pharm Pharmaceut Sci. 2010;2(1):1\u20136."}, {"Citation": "Carhart-Harris R.L., Nutt D.J. Serotonin and brain function: a tale of two receptors. J\u00a0Psychopharmacol. 2017;31(9):1091\u20131120. doi: 10.1177/0269881117725915.", "ArticleIdList": ["10.1177/0269881117725915", "PMC5606297", "28858536"]}, {"Citation": "Martin E.I., Ressler K.J., Binder E., Nemeroff C.B. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin. 2009;32(3):549\u2013575. doi: 10.1016/j.psc.2009.05.004.", "ArticleIdList": ["10.1016/j.psc.2009.05.004", "PMC3684250", "19716990"]}, {"Citation": "Babaev O., Chatain C.P., Krueger-Burg D. Inhibition in the amygdala anxiety circuitry. Exp Mol Med. 2018;50(4):18. doi: 10.1038/s12276-018-0063-8.", "ArticleIdList": ["10.1038/s12276-018-0063-8", "PMC5938054", "29628509"]}, {"Citation": "Yin L., Zheng L., Xu L., et al. In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics. BMC Compl Alternative Med. 2015;15:41. doi: 10.1186/s12906-015-0579-6.", "ArticleIdList": ["10.1186/s12906-015-0579-6", "PMC4354738", "25879470"]}, {"Citation": "Khan T., Lawrence A.J., Azad I., Raza S., Joshi S., Khan A.R. Computational drug designing and prediction of important parameters using in silico methods - a review. Curr Comput-Aid Drug. 2019;15(5):384\u2013397. doi: 10.2174/1573399815666190326120006.", "ArticleIdList": ["10.2174/1573399815666190326120006", "30914032"]}, {"Citation": "Nantasenamat C., Isarankura-Na-Ayudhya C., Prachayasittikul V. Advances in computational methods to predict the biological activity of compounds. Expet Opin Drug Discov. 2010;5(7):633\u2013654. doi: 10.1517/17460441.2010.492827.", "ArticleIdList": ["10.1517/17460441.2010.492827", "22823204"]}, {"Citation": "Lee H., Le H.V., Wu R., et al. Mechanism of inactivation of GABA aminotransferase by (E)- and (Z)-(1S,3S)-3-Amino-4-fluoromethylenyl-1-cyclopentanoic acid. ACS Chem Biol. 2015;10(9):2087\u20132098. doi: 10.1021/acschembio.5b00212.", "ArticleIdList": ["10.1021/acschembio.5b00212", "PMC4575653", "26110556"]}, {"Citation": "Awad R., Muhammad A., Durst T., Trudeau V.L., Arnason J.T. Bioassay-guided fractionation of lemon balm (Melissa officinalis L.) using an in\u00a0vitro measure of GABA transaminase activity. Phytother Res. 2009;8:1075\u20131081. doi: 10.1002/ptr.2712.", "ArticleIdList": ["10.1002/ptr.2712", "19165747"]}, {"Citation": "Scaglione F., Zangara A. Valeriana officinalis and Melissa officinalis extracts normalize brain levels of GABA and glutamate altered by chronic stress. J\u00a0Sleep Disord Manag. 2017;3:16. doi: 10.23937/2572-4053.1510016.", "ArticleIdList": ["10.23937/2572-4053.1510016"]}, {"Citation": "Gong X., Shao Y., Li B., Chen L., Wang C., Chen Y. \u03b3-Aminobutyric acid transporter-1 is involved in anxiety-like behaviors and cognitive function in knockout mice. Exp Ther Med. 2015;2:653\u2013658. doi: 10.3892/etm.2015.2577.", "ArticleIdList": ["10.3892/etm.2015.2577", "PMC4509144", "26622370"]}, {"Citation": "Appel K., Rose T., Fiebich B., Kammler T., Hoffmann C., Weiss G. Modulation of the \u03b3-aminobutric acid (GABA) system by Passiflora incarnata L. Phytother Res. 2010;6:838\u2013843. doi: 10.1002/ptr.3352.", "ArticleIdList": ["10.1002/ptr.3352", "21089181"]}, {"Citation": "Lorenz-Guertin J.M., Jacob T.C. GABA type a receptor trafficking and the architecture of synaptic inhibition. Dev Neurobiol. 2018;78(3):238\u2013270. doi: 10.1002/dneu.22536.", "ArticleIdList": ["10.1002/dneu.22536", "PMC6589839", "28901728"]}, {"Citation": "Zhu S., Noviello C.M., Teng J., Walsh R.M., Kim J.J., Hibbs R.E. Structure of a human synaptic GABAA receptor. Nature. 2018;559:67\u201372. doi: 10.1038/s41586-018-0255-3.", "ArticleIdList": ["10.1038/s41586-018-0255-3", "PMC6220708", "29950725"]}, {"Citation": "Wu C., Sun D. GABA receptors in brain development, function, and injury. Metab Brain Dis. 2015;30(2):367\u2013379. doi: 10.1007/s11011-014-9560-1.", "ArticleIdList": ["10.1007/s11011-014-9560-1", "PMC4231020", "24820774"]}, {"Citation": "Huang X., Liu T., Gu J., et al. 3D-QSAR model of flavonoids binding at benzodiazepine site in GABAA receptors. J\u00a0Med Chem. 2001;44(12):1883\u20131891. doi: 10.1021/jm000557p.", "ArticleIdList": ["10.1021/jm000557p", "11384234"]}, {"Citation": "Strawn J.R., Geracioti L., Rajdev N., Clemenza K., Levine A. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expet Opin Pharmacother. 2018;19(10):1057\u20131070. doi: 10.1080/14656566.2018.1491966.", "ArticleIdList": ["10.1080/14656566.2018.1491966", "PMC6340395", "30056792"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "9", "Day": "30"}, {"Year": "2021", "Month": "7", "Day": "22"}, {"Year": "2021", "Month": "8", "Day": "28"}, {"Year": "2022", "Month": "6", "Day": "24", "Hour": "2", "Minute": "11"}, {"Year": "2022", "Month": "6", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "25", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "9", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["35747359", "PMC9209824", "10.1016/j.jtcme.2021.08.012", "S2225-4110(21)00104-8"]}}], "PubmedBookArticle": []}